ABBV Stock Analysis: Buy, Sell, or Hold?
ABBV - ABBVIE INC.
$248.00
-0.08 (-0.03%)
▼
5d:
-2.65%
30d:
+10.25%
90d:
+19.27%
BUY
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Jul 31, 2026
17d
Smart Money Accumulation
None View Scanner →
Strength: 8.6/10
Get Alerted When ABBV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called ABBV this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ABBV shows positive signals but monitor for confirmation. Market pricing in 2.3% growth. Moderate conviction.
💡 BUY OPPORTUNITY: ABBV shows positive signals but monitor for confirmation. Market pricing in 2.3% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$360.50
Based on 9.4% avg growth
INTRINSIC VALUE TODAY
$223.84
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ABBV is currently trading at $248.00, which is considered slightly high relative to its 30-day fair value range of $223.93 to $251.66. The stock's valuation (Forward PE: 15.2) is in line with its historical norms (14.2). At these levels, the market is pricing in 2.3% annual earnings growth.
Technical Outlook: Technically, ABBV is in a strong uptrend. The price is currently testing key support at $244.61. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ABBV is in a strong uptrend. The price is currently testing key support at $244.61. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$223.93 -
$251.66
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.8%
All Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($262.93)
- BULLISH: Expecting earnings turnaround to 2.3% growth with 12.4% revenue growth
Trading Range Analysis
30-Day Trading Range
$223.93 -
$251.66
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$244.61
Resistance Level
$261.64
Current Trend
Strong Uptrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
15.23
Wall Street Target
$262.93
(+6.0%)
Revenue Growth (YoY)
12.4%
Earnings Growth (YoY)
-46.2%
Profit Margin
5.8%
Valuation Premium vs History
+2.3% premium
PE vs Historical
15.2 vs 14.2
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.3%
(market-implied from PE analysis)
1-Year Target
$253.70
(+2%)
2-Year Target
$259.54
(+5%)
3-Year Target
$265.51
(+7%)
3-Yr Target (if PE normalizes)
(PE: 15→14)
PE COMPRESSION
$247.59
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 14.7%)
$535.16
(+116%)
Base:
(SPY PE: 15.2, Growth: 14.7%)
$374.16
(+51%)
Bear:
(PE: 12.9, Growth: 14.7%)
$318.03
(+28%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (18x PE), but valuation improves significantly next year (15x PE) as earnings recover.
Forward PE: 17.73 | Forward EPS (Implied): $13.99
Bull Case
$299.56
(+21%)
Analyst growth 15.0%, PE expands to 18.6
Base Case
$248.08
(0%)
Market implied 0.0%, PE stable at 17.7
Bear Case
$189.78
(-24%)
Severe decline -15.0%, PE contracts to 16.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 13, 2026 5:39 PM ET
Data refreshes hourly during market hours. Next update: 6:39 PM
Data refreshes hourly during market hours. Next update: 6:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ABBV showing a specific setup today?
Insider Activity (6 Months)
2
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
SELL
2026-03-30
David Ryan Purdue
SELL
5230 shares
2026-03-04
Perry C Siatis
SELL
22381 shares
2026-02-25
Featured in Portfolios
ABBV is a key holding in these high-performance investment strategies.
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
31 analysts |
$1240 | 58 HOLD |
|
GILD
Gilead Sciences Inc |
BUY
30 analysts |
$158 | 64 BUY |
|
BIIB
Biogen Inc |
HOLD
37 analysts |
$223 | 59 HOLD |
|
AMGN
Amgen Inc |
HOLD
32 analysts |
$356 | 56 HOLD |
|
MRK
Merck & Company Inc |
BUY
26 analysts |
$132 | 59 HOLD |
Advanced ABBV Option Strategies
Professional options setups generated by AI based on today's ABBV price and gamma walls.
